Study Reveals 59% of Overdose Deaths Involved Stimulants from 2021 to 2024
A CDC report highlights that nearly 60% of overdose deaths in the US from 2021 to 2024 involved stimulants, emphasizing the need for targeted treatment approaches.
A recent investigation into overdose fatalities from January 2021 to June 2024 indicates that nearly 60% of these deaths involved stimulants, according to data published in the August 28 issue of the Morbidity and Mortality Weekly Report by the CDC. Lauren J. Tanz, Sc.D., and her team analyzed data from the CDC's Unintentional Drug Overdose Reporting System, uncovering a significant rise in stimulant-related overdose deaths across the United States.
The study found that 59.0% of overdose deaths involved stimulants, with 43.1% involving both stimulants and opioids, and 15.9% involving stimulants without opioids. Notably, individuals who overdosed on stimulants without opioids tended to be older—over 45 years—and had a higher prevalence of cardiovascular disease, compared to those who combined stimulants and opioids.
Between 2018 and 2023, there has been a marked increase in overdose death rates associated with stimulants like cocaine and psychostimulants such as methamphetamine. The increase was particularly pronounced among non-Hispanic American Indian or Alaska Native populations, with rates rising from 11.0 to 32.9, and among non-Hispanic Black or African American populations, with rates climbing from 9.1 to 24.3. These trends are driven by deaths involving both stimulants and opioids.
The findings underscore the urgent need for expanding access to evidence-based behavioral treatments, like contingency management, aimed at addressing stimulant use disorder effectively. As the overdose crisis continues to evolve, targeted interventions and comprehensive strategies are essential to combat the rising number of stimulant-involved fatalities.
Source: Medical Xpress
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Study Finds Over-the-Counter Contraceptive Pills Significantly Improve Access to Birth Control
A recent study demonstrates that OTC birth control pills significantly improve access to contraception, especially for underserved populations, enhancing reproductive autonomy and reducing barriers to care.
CDC Panel Rejects Merck's Childhood Combination Vaccine Schedule Change
The CDC advisory committee has voted against recommending Merck's combined vaccine for children under 4, citing safety concerns about seizures. The decision highlights ongoing debates over vaccine safety and immunization strategies in the U.S.
Polygenic Risk Score Shows Promise in Predicting Future Breast Cancer in Early-Stage Patients
A new study reveals that a 313-gene polygenic risk score can predict the future risk of breast cancer in women with early-stage diagnoses, offering a promising tool for personalized treatment planning.
Disparities in Heart Failure Onset: Black Adults Face Diagnosis Nearly 14 Years Earlier Than White Peers
A Northwestern University study reveals Black adults in the U.S. face heart failure nearly 14 years earlier than white patients, highlighting the impact of social and economic factors on health disparities.